Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 20 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 20:35 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-415649 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 3,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. F2 · derivative.expiration_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. Read SEC document |
| October 02, 2026 Filed Oct 6, 2026 20:35 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-415649 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-297456 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,880 Underlying: Common Stock · 3,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. F2 · derivative.expiration_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-297456 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267501 · ownership.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. F2 · ownership.nature: Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. F3 · ownership.nature: Joseph Edelman is the managing member of the Advisor. The Advisor serves as the investment manager to Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Each of Mr. Edelman, the Advisor and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, the Advisor or the Master Fund is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Stone Adam LeoDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267489 · ownership.xml · derivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Ganot IlanDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267502 · ownership.xml · derivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Nagendran SukumarDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267504 · ownership.xml · derivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
SMITH IAN FDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267503 · ownership.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Keresty GeorgiaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267500 · ownership.xml · derivative · entry 1 Keresty Georgia · CIK 0001773532 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Freed Martin IDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267499 · ownership.xml · derivative · entry 1 Freed Martin I · CIK 0001676653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Kahn ClareDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267496 · ownership.xml · derivative · entry 1 Kahn Clare · CIK 0001849236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 20:05 UTC |
Sullivan Lynne MarieDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 77,500 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001193125-26-267494 · ownership.xml · derivative · entry 1 Sullivan Lynne Marie · CIK 0001727640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2036-06-10 F1 · derivative.exercise_date: This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| April 02, 2026 Filed Apr 2, 2026 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-140056 · ownership.xml · derivative · entry 2 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,320 Underlying: Common Stock · 3,441 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. F2 · derivative.expiration_date: The restricted stock units were granted on January 2, 2026 and vested in equal quarterly installments beginning three months from the date of grant, with the final installment vesting 12 months from the date of grant. Read SEC document |
| April 02, 2026 Filed Apr 2, 2026 20:05 UTC |
SMITH IAN FDirector
|
Exercise / conversionCommon Stock | 3,441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-140056 · ownership.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:00 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
EDELMAN JOSEPHDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
|
GrantPre-Funded Warrant (right to buy) · Derivative | 8,912,655 | $5.61 Strike: $0.00 | $49,991,081.90 |
DisclosureSEC source: 0001193125-26-102076 · ownership.xml · derivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,912,655 Underlying: Common Stock · 8,912,655 shares Expires not disclosed F1 · derivative.exercise_date: The terms of the Pre-Funded Warrants provide that such warrants may not be exercised if, after such exercise, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the shares of Common Stock then issued and outstanding after giving effect to such exercise (the "Beneficial Ownership Limitation"). As of the date hereof, the Beneficial Ownership Limitation does not permit the Master Fund (as defined herein) to exercise any of its Warrants. F2 · derivative.expiration_date: The Pre-Funded Warrants do not expire. F3 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. F4 · ownership.nature: Each of Mr. Edelman, the Advisor, and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:32 UTC |
Ganot IlanDirector
|
SaleCommon Stock | 2,658 | $5.82 | $15,478.33 |
DisclosureSEC source: 0001193125-26-057868 · ownership.xml · nonDerivative · entry 2 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 27,474 F3 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. F3 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:38 UTC |
Cumbo AlexanderDirector · President and CEO
|
SaleCommon Stock | 16,644 | $5.82 | $96,923.01 |
DisclosureSEC source: 0001193125-26-057878 · ownership.xml · nonDerivative · entry 2 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,405 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:31 UTC |
Herzich PaulChief Technology Officer
|
SaleCommon Stock | 3,616 | $5.82 | $21,057.05 |
DisclosureSEC source: 0001193125-26-057865 · ownership.xml · nonDerivative · entry 2 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,638 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
SaleCommon Stock | 4,134 | $5.82 | $24,073.52 |
DisclosureSEC source: 0001193125-26-057872 · ownership.xml · nonDerivative · entry 2 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,318 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:31 UTC |
Howton David TChief Operating Officer
|
SaleCommon Stock | 7,469 | $5.82 | $43,494.23 |
DisclosureSEC source: 0001193125-26-057863 · ownership.xml · nonDerivative · entry 2 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,077 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:25 UTC |
Tan KevinCFO & Treasurer
|
SaleCommon Stock | 5,404 | $5.82 | $31,469.11 |
DisclosureSEC source: 0001193125-26-057855 · ownership.xml · nonDerivative · entry 2 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,422 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 02:28 UTC |
Brooks GabrielChief Medical Officer
|
SaleCommon Stock | 0 | $5.82 | $0.00 |
DisclosureSEC source: 0001193125-26-057859 · ownership.xml · nonDerivative · entry 2 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,466 F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:32 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057868 · ownership.xml · derivative · entry 5 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 9,722 Underlying: Common Stock · 4,861 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. F6 · derivative.expiration_date: On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:32 UTC |
Ganot IlanDirector
|
Exercise / conversionCommon Stock | 4,861 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057868 · ownership.xml · nonDerivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 30,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:38 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 30,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057878 · ownership.xml · derivative · entry 3 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,063 Underlying: Common Stock · 30,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:38 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,031 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057878 · ownership.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:31 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057865 · ownership.xml · derivative · entry 3 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,376 Underlying: Common Stock · 7,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:31 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionCommon Stock | 7,187 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057865 · ownership.xml · nonDerivative · entry 1 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057872 · ownership.xml · derivative · entry 3 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 8,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:34 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionCommon Stock | 8,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057872 · ownership.xml · nonDerivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:31 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057863 · ownership.xml · derivative · entry 3 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,376 Underlying: Common Stock · 14,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:31 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionCommon Stock | 14,687 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057863 · ownership.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:25 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057855 · ownership.xml · derivative · entry 3 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 10,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The restricted stock units were granted on February 13, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The restricted stock units were granted on February 13, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:25 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionCommon Stock | 10,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057855 · ownership.xml · nonDerivative · entry 1 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:28 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-057859 · ownership.xml · derivative · entry 3 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,876 Underlying: Common Stock · 10,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F4 · derivative.exercise_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. F4 · derivative.expiration_date: The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. Read SEC document |
| February 13, 2026 Filed Feb 19, 2026 02:28 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionCommon Stock | 10,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-057859 · ownership.xml · nonDerivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:01 UTC |
Ganot IlanDirector
|
SaleCommon Stock | 7,205 | $6.44 | $46,413.89 |
DisclosureSEC source: 0001193125-26-041516 · ownership.xml · nonDerivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 25,271 F1 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:05 UTC |
Howton David TChief Operating Officer
|
SaleCommon Stock | 18,894 | $6.44 | $121,713.26 |
DisclosureSEC source: 0001193125-26-041523 · ownership.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,859 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:01 UTC |
Cumbo AlexanderDirector · President and CEO
|
SaleCommon Stock | 48,913 | $6.44 | $315,092.65 |
DisclosureSEC source: 0001193125-26-041519 · ownership.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,018 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:00 UTC |
Tan KevinCFO & Treasurer
|
SaleCommon Stock | 14,783 | $6.44 | $95,230.61 |
DisclosureSEC source: 0001193125-26-041514 · ownership.xml · nonDerivative · entry 1 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,201 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 22:59 UTC |
Brooks GabrielChief Medical Officer
|
SaleCommon Stock | 12,616 | $6.44 | $81,271.01 |
DisclosureSEC source: 0001193125-26-041511 · ownership.xml · nonDerivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,092 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 22:57 UTC |
Hanrahan JessieChief Regulatory Officer
|
SaleCommon Stock | 12,348 | $6.44 | $79,544.58 |
DisclosureSEC source: 0001193125-26-041507 · ownership.xml · nonDerivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,327 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 22:56 UTC |
Herzich PaulChief Technology Officer
|
SaleCommon Stock | 10,905 | $6.44 | $70,248.92 |
DisclosureSEC source: 0001193125-26-041506 · ownership.xml · nonDerivative · entry 1 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,067 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
SaleCommon Stock | 26,837 | $6.44 | $172,747.09 |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · nonDerivative · entry 3 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,984 F3 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
SaleCommon Stock | 80,258 | $6.44 | $516,612.72 |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · nonDerivative · entry 3 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,931 F3 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Cumbo on August 18, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Cumbo. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
SaleCommon Stock | 26,535 | $6.44 | $170,803.14 |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · nonDerivative · entry 3 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,675 F3 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Hanrahan on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Hanrahan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
SaleCommon Stock | 28,335 | $6.44 | $182,389.56 |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · nonDerivative · entry 3 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,708 F4 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
SaleCommon Stock | 37,771 | $6.44 | $243,128.15 |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · nonDerivative · entry 3 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,753 F3 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
SaleCommon Stock | 26,250 | $6.44 | $168,968.63 |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · nonDerivative · entry 3 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,972 F3 · shares: This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.